FC
ZBH icon

Farringdon Capital’s Zimmer Biomet ZBH Stock Holding History

Farringdon Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,324
Closed -$426K – 670
2025
Q3 		$426K Sell
4,324
-1,935
-31% -$192K 0.11% 271
2025
Q2 		$571K Buy
+6,259
New +$605K 0.19% 164
2025
Q1 		– Sell
-4,891
Closed -$517K – 633
2024
Q4 		$517K Buy
+4,891
New +$525K 0.21% 138

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Farringdon Capital's ZBH Position: Q4 2025 in Review

Farringdon Capital sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 4,324 shares — an estimated $426K sold.

Farringdon Capital first reported a position in ZBH in Q4 2024 and held it in 3 quarters. The position peaked at $571K in Q2 2025. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Farringdon Capital reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Farringdon Capital sold 4,324 Zimmer Biomet shares in Q4 2025, an estimated $426K.
  • Farringdon Capital first reported a position in Zimmer Biomet in Q4 2024 and held it in 3 quarters.
  • Farringdon Capital's Zimmer Biomet position peaked at $571K in Q2 2025.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Farringdon Capital's 13F filing for Q4 2025, filed 17 Feb 2026.